Novomix 30 Flexpen 100IU/ml

Novomix 30 100IU/ml Flexpen 3 ml is a combination of rapid-acting human insulin and longer-acting insulin analogue to treat diabetes mellitus in children (above 2 years of age) and adults. It maintains blood sugar levels in adults and children. Diabetes mellitus is a condition that affects the way your body processes glucose. In Diabetes Mellitus Type 1, the body does not make enough insulin to control blood sugar levels. In Diabetes Mellitus type 2, either the body stops producing enough insulin (the hormone which helps to decrease sugar levels in the blood), or there is resistance to insulin action. As a result, insulin is produced in large amounts, but it cannot act on the organs of the body.

Novomix 30 100IU/ml Flexpen 3 ml is a combination medicine that contains insulin aspart (rapid-acting), and the other is insulin aspart protamine (longer-acting). Insulin aspart has a fast onset of action, and insulin aspart protamine has a prolonged duration of action. Together, they ensure rapid and stable sugar control by enabling the reuptake of sugar in muscle and fat cells and decreasing sugar production in the liver.

Take Novomix 30 100IU/ml Flexpen 3 ml as prescribed by your doctor. You are advised to take Novomix 30 100IU/ml Flexpen 3 ml for as long as your doctor has prescribed it for you, depending on your medical conditions. You may experience weight gain, injection site allergic reaction, rash, lipodystrophy (skin thickening or pits at the injection site), hypoglycaemia (low blood glucose level), and itching. Most of these side effects of Novomix 30 100IU/ml Flexpen 3 ml do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.